Fluorine in PDB 1dvy: Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Protein crystallography data
The structure of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid, PDB code: 1dvy
was solved by
T.Klabunde,
H.M.Petrassi,
V.B.Oza,
J.W.Kelly,
J.C.Sacchettini,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
8.00 /
1.90
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
43.290,
86.030,
65.230,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.2 /
20.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
(pdb code 1dvy). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid, PDB code: 1dvy:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 1dvy
Go back to
Fluorine Binding Sites List in 1dvy
Fluorine binding site 1 out
of 6 in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F125
b:33.3
occ:0.28
|
F1
|
A:BPD125
|
0.0
|
33.3
|
0.3
|
C1
|
A:BPD125
|
1.3
|
33.6
|
0.3
|
F2
|
A:BPD125
|
2.1
|
32.2
|
0.3
|
F3
|
A:BPD125
|
2.1
|
33.8
|
0.3
|
C2
|
A:BPD125
|
2.3
|
33.6
|
0.3
|
C7
|
A:BPD125
|
3.0
|
33.9
|
0.3
|
CB
|
A:ALA108
|
3.3
|
21.2
|
1.0
|
C3
|
A:BPD125
|
3.4
|
34.1
|
0.3
|
C
|
A:ALA108
|
3.9
|
18.8
|
1.0
|
N
|
A:ALA109
|
4.0
|
17.2
|
1.0
|
CG2
|
A:THR119
|
4.1
|
26.2
|
1.0
|
C
|
A:ALA109
|
4.2
|
18.1
|
1.0
|
CA
|
A:ALA108
|
4.2
|
20.2
|
1.0
|
O
|
A:ALA108
|
4.2
|
19.6
|
1.0
|
N
|
A:LEU110
|
4.3
|
16.7
|
1.0
|
C6
|
A:BPD125
|
4.3
|
34.1
|
0.3
|
CA
|
A:ALA109
|
4.4
|
17.9
|
1.0
|
CB
|
A:LEU110
|
4.4
|
16.0
|
1.0
|
O
|
A:ALA109
|
4.4
|
17.6
|
1.0
|
C4
|
A:BPD125
|
4.6
|
33.6
|
0.3
|
CA
|
A:LEU110
|
4.8
|
15.9
|
1.0
|
C5
|
A:BPD125
|
5.0
|
34.3
|
0.3
|
|
Fluorine binding site 2 out
of 6 in 1dvy
Go back to
Fluorine Binding Sites List in 1dvy
Fluorine binding site 2 out
of 6 in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F125
b:33.3
occ:0.28
|
F1
|
A:BPD125
|
0.0
|
33.3
|
0.3
|
C1
|
A:BPD125
|
1.3
|
34.0
|
0.3
|
F2
|
A:BPD125
|
2.1
|
33.0
|
0.3
|
F3
|
A:BPD125
|
2.1
|
33.6
|
0.3
|
C2
|
A:BPD125
|
2.3
|
33.5
|
0.3
|
C7
|
A:BPD125
|
3.0
|
33.9
|
0.3
|
CB
|
B:ALA108
|
3.2
|
21.6
|
1.0
|
C3
|
A:BPD125
|
3.4
|
34.6
|
0.3
|
CG2
|
B:THR119
|
3.9
|
26.1
|
1.0
|
C
|
B:ALA108
|
3.9
|
19.3
|
1.0
|
N
|
B:ALA109
|
4.0
|
18.6
|
1.0
|
CA
|
B:ALA108
|
4.2
|
21.2
|
1.0
|
O
|
B:ALA108
|
4.2
|
22.2
|
1.0
|
C
|
B:ALA109
|
4.3
|
18.3
|
1.0
|
C6
|
A:BPD125
|
4.3
|
34.2
|
0.3
|
N
|
B:LEU110
|
4.4
|
17.3
|
1.0
|
CA
|
B:ALA109
|
4.5
|
19.2
|
1.0
|
CB
|
B:LEU110
|
4.5
|
17.2
|
1.0
|
O
|
B:ALA109
|
4.5
|
19.9
|
1.0
|
C4
|
A:BPD125
|
4.6
|
33.7
|
0.3
|
CA
|
B:LEU110
|
4.9
|
17.5
|
1.0
|
CB
|
B:THR119
|
4.9
|
22.0
|
1.0
|
C5
|
A:BPD125
|
5.0
|
34.5
|
0.3
|
|
Fluorine binding site 3 out
of 6 in 1dvy
Go back to
Fluorine Binding Sites List in 1dvy
Fluorine binding site 3 out
of 6 in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F125
b:32.2
occ:0.28
|
F2
|
A:BPD125
|
0.0
|
32.2
|
0.3
|
C1
|
A:BPD125
|
1.3
|
33.6
|
0.3
|
F1
|
A:BPD125
|
2.1
|
33.3
|
0.3
|
F3
|
A:BPD125
|
2.1
|
33.8
|
0.3
|
C2
|
A:BPD125
|
2.3
|
33.6
|
0.3
|
C3
|
A:BPD125
|
2.7
|
34.1
|
0.3
|
C7
|
A:BPD125
|
3.7
|
33.9
|
0.3
|
CB
|
A:LEU110
|
3.7
|
16.0
|
1.0
|
CD2
|
A:LEU110
|
4.0
|
20.7
|
1.0
|
C4
|
A:BPD125
|
4.1
|
33.6
|
0.3
|
CG
|
A:LEU110
|
4.4
|
20.0
|
1.0
|
N
|
A:LEU110
|
4.7
|
16.7
|
1.0
|
CA
|
A:LEU110
|
4.7
|
15.9
|
1.0
|
C6
|
A:BPD125
|
4.8
|
34.1
|
0.3
|
CD1
|
A:LEU110
|
4.9
|
20.1
|
1.0
|
CG2
|
A:THR119
|
5.0
|
26.2
|
1.0
|
C5
|
A:BPD125
|
5.0
|
34.3
|
0.3
|
|
Fluorine binding site 4 out
of 6 in 1dvy
Go back to
Fluorine Binding Sites List in 1dvy
Fluorine binding site 4 out
of 6 in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F125
b:33.0
occ:0.28
|
F2
|
A:BPD125
|
0.0
|
33.0
|
0.3
|
C1
|
A:BPD125
|
1.3
|
34.0
|
0.3
|
F1
|
A:BPD125
|
2.1
|
33.3
|
0.3
|
F3
|
A:BPD125
|
2.1
|
33.6
|
0.3
|
C2
|
A:BPD125
|
2.3
|
33.5
|
0.3
|
C3
|
A:BPD125
|
2.7
|
34.6
|
0.3
|
C7
|
A:BPD125
|
3.7
|
33.9
|
0.3
|
CB
|
B:LEU110
|
3.8
|
17.2
|
1.0
|
CD2
|
B:LEU110
|
4.1
|
22.7
|
1.0
|
C4
|
A:BPD125
|
4.1
|
33.7
|
0.3
|
CG
|
B:LEU110
|
4.5
|
21.4
|
1.0
|
CG2
|
B:THR119
|
4.8
|
26.1
|
1.0
|
C6
|
A:BPD125
|
4.8
|
34.2
|
0.3
|
N
|
B:LEU110
|
4.8
|
17.3
|
1.0
|
CA
|
B:LEU110
|
4.8
|
17.5
|
1.0
|
C5
|
A:BPD125
|
5.0
|
34.5
|
0.3
|
|
Fluorine binding site 5 out
of 6 in 1dvy
Go back to
Fluorine Binding Sites List in 1dvy
Fluorine binding site 5 out
of 6 in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F125
b:33.8
occ:0.28
|
F3
|
A:BPD125
|
0.0
|
33.8
|
0.3
|
C1
|
A:BPD125
|
1.3
|
33.6
|
0.3
|
F1
|
A:BPD125
|
2.1
|
33.3
|
0.3
|
F2
|
A:BPD125
|
2.1
|
32.2
|
0.3
|
C2
|
A:BPD125
|
2.3
|
33.6
|
0.3
|
C7
|
A:BPD125
|
2.9
|
33.9
|
0.3
|
CD1
|
A:LEU17
|
3.3
|
23.2
|
1.0
|
C3
|
A:BPD125
|
3.5
|
34.1
|
0.3
|
CB
|
A:LEU110
|
3.5
|
16.0
|
1.0
|
CG
|
A:LEU17
|
4.0
|
19.9
|
1.0
|
CD1
|
A:LEU110
|
4.0
|
20.1
|
1.0
|
CA
|
A:LEU110
|
4.1
|
15.9
|
1.0
|
CG
|
A:LEU110
|
4.2
|
20.0
|
1.0
|
O
|
A:ALA109
|
4.2
|
17.6
|
1.0
|
CB
|
A:LEU17
|
4.2
|
18.7
|
1.0
|
N
|
A:LEU110
|
4.2
|
16.7
|
1.0
|
C6
|
A:BPD125
|
4.3
|
34.1
|
0.3
|
CD2
|
A:LEU110
|
4.3
|
20.7
|
1.0
|
C
|
A:ALA109
|
4.3
|
18.1
|
1.0
|
C4
|
A:BPD125
|
4.6
|
33.6
|
0.3
|
C5
|
A:BPD125
|
5.0
|
34.3
|
0.3
|
CB
|
A:ALA108
|
5.0
|
21.2
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 1dvy
Go back to
Fluorine Binding Sites List in 1dvy
Fluorine binding site 6 out
of 6 in the Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of Transthyretin in Complex with N-(M- Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F125
b:33.6
occ:0.28
|
F3
|
A:BPD125
|
0.0
|
33.6
|
0.3
|
C1
|
A:BPD125
|
1.3
|
34.0
|
0.3
|
F1
|
A:BPD125
|
2.1
|
33.3
|
0.3
|
F2
|
A:BPD125
|
2.1
|
33.0
|
0.3
|
C2
|
A:BPD125
|
2.3
|
33.5
|
0.3
|
C7
|
A:BPD125
|
2.9
|
33.9
|
0.3
|
CD1
|
B:LEU17
|
3.3
|
23.4
|
1.0
|
C3
|
A:BPD125
|
3.5
|
34.6
|
0.3
|
CB
|
B:LEU110
|
3.7
|
17.2
|
1.0
|
CG
|
B:LEU17
|
4.0
|
23.7
|
1.0
|
CD1
|
B:LEU110
|
4.1
|
21.0
|
1.0
|
CA
|
B:LEU110
|
4.2
|
17.5
|
1.0
|
C6
|
A:BPD125
|
4.3
|
34.2
|
0.3
|
CG
|
B:LEU110
|
4.3
|
21.4
|
1.0
|
CB
|
B:LEU17
|
4.3
|
20.2
|
1.0
|
O
|
B:ALA109
|
4.3
|
19.9
|
1.0
|
N
|
B:LEU110
|
4.3
|
17.3
|
1.0
|
CD2
|
B:LEU110
|
4.4
|
22.7
|
1.0
|
C
|
B:ALA109
|
4.4
|
18.3
|
1.0
|
C4
|
A:BPD125
|
4.6
|
33.7
|
0.3
|
CB
|
B:ALA108
|
4.9
|
21.6
|
1.0
|
C5
|
A:BPD125
|
5.0
|
34.5
|
0.3
|
|
Reference:
T.Klabunde,
H.M.Petrassi,
V.B.Oza,
P.Raman,
J.W.Kelly,
J.C.Sacchettini.
Rational Design of Potent Human Transthyretin Amyloid Disease Inhibitors. Nat.Struct.Biol. V. 7 312 2000.
ISSN: ISSN 1072-8368
PubMed: 10742177
DOI: 10.1038/74082
Page generated: Wed Jul 31 11:06:28 2024
|